Longevity
Ten Things to Know About Antiretroviral Therapy for Biological Aging
1. Human proof of concept Recent clinical observations have demonstrated the first human proof-of-concept that an FDA-approved antiretroviral…
Section
Longevity
Longevity
From the newsroom
Stories
Longevity
Electromagnetic Gene Expression Control Achieves Lifespan Extension in Progeroid Mice via OSK Reprogramming
In a major advancement for genetic medicine and longevity research, scientists at Seoul National University have successfully demonstrated…
Longevity
ARPA-H Commits $144 Million to Accelerate Aging and Longevity Research Programs
The Advanced Research Projects Agency for Health (ARPA-H), an agency operating within the U.S. Department of Health and…
Longevity
Ten Things to Know About the FDA Clearance for Epigenetic Reprogramming Therapy ER-100
1. Regulatory milestone achieved The United States Food and Drug Administration has officially granted clearance for the first…
Longevity
U.S. ARPA-H Invests $144 Million in PROSPR Program to Advance Healthspan-Extending Human Trials
The Advanced Research Projects Agency for Health (ARPA-H) has announced a major commitment to transforming the field of…
Longevity
Ten Things to Know About the Japanese Study on Mitochondrial Proteins and Aging
1. Research Origin and Academic Leadership The groundbreaking study was conducted by a team of scientists at Osaka…
Longevity
New 2026 Mouse Study Examines Pinealon’s Longevity Potential Against Rapamycin, 17α-Estradiol, and Other Interventions
A groundbreaking new preprint study released in February 2026 has provided the first direct comparative data between the…
Longevity
Strength Training Reduces Estimated Brain Age by Up to 2.3 Years in Older Adults with Lasting Effects
A new study published in the scientific journal GeroScience indicates that regular strength training may significantly slow down…